Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP)

Biochemical Pharmacology

Volumn 52, Issue 10, 1996, Pages 1569-1576

  Slapak, Christopher A ^b   Martell, Robin L ^a   Terashima, Masanori ^b   Levy, Stuart B ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

drug efflux; MRP; vincristine resistance

Indexed keywords

DAUNORUBICIN; GLYCOPROTEIN P; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; VINCRISTINE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG TRANSPORT; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MEMBRANE PERMEABILITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

2,4-DINITROPHENOL; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AZIDES; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELL MEMBRANE; DAUNORUBICIN; DIGITONIN; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MICE; P-GLYCOPROTEIN; SODIUM AZIDE; SUBCELLULAR FRACTIONS; UNCOUPLING AGENTS; VINCRISTINE;

EID: 0030598410     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00561-8     Document Type: Article

References (33)

1. 1. Juranka PF, Zastawny RL and Ling V, P-glycoprotein: Multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J 3: 2583-2592, 1989.
2. 2. Gottesman MM, How cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res 53: 747-754, 1993.
3. 3. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM and Deeley RG, Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902-5910, 1994.
4. 4. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC and Deeley RG, Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357-361, 1994.
5. 5. Zaman GJR, Flens MJ, van Leusden MR, de Haas M, Mülder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ and Borst P, The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91: 8822-8826, 1994.
6. 6. Slapak CA, Mizunuma N and Kufe DW, Expresssion of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood 84: 3113-3121, 1994.
7. 7. Slapak CA, Fracasso PM, Martell RL, Toppmeyer DL, Lecerf J-M and Levy SB, Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Cancer Res 54: 5607-5613, 1994.
8. 8. Brock I, Hipfner DR, Nielsen BS, Jensen PB, Deeley RG, Cole SPC and Sehested M, Sequential coexpression of the multidrug genes MRP and mdrl and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res 55: 459-462, 1995.
9. 9. Prokesch RC and Hand WL, Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 21: 373-380, 1982.
10. 10. Slapak CA, Lecerf J-M, Daniel JC and Levy SB, Energy-dependent accumulation of daunorubicin into subcellular compartments of human cells and cytoplasts. J Biol Chem 267: 10638-10644, 1992.
11. 11. Slapak CA, Daniel JC and Levy SB, Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: Decreased anthracycline uptake precedes increased P-glycoprotein expression. Cancer Res 50: 7895-7901, 1990.
12. 12. Garman D, Albers L and Center MS, Identification and characterization of a plasma membrane phosphoprotein which is present in Chinese hamster lung cells resistant to adriamycin. Biochem Pharmacol 32: 3633-3637, 1983.
13. 13. Bradford MM, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
14. 14. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
15. 15. Tartakoff AM, Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32: 1026-1028, 1983.
16. 16. Versantvoort CHM, Broxterman HJ, Feller N, Dekker H, Kuiper CM and Lankelma J, Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistance cell lines using digitonin. Int J Cancer 50: 906-911, 1992.
17. 17. Gores GJ, Nieminen A-L, Wray BE, Herman B and Lemasters JJ, Intracellular pH during "chemical hypoxia" in cultured rat hepatocytes. J Clin Invest 83: 386-396, 1989.
18. 18. Marquardt D and Center MS, Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: Evidence for nuclear drug accumulation and redistribution of resistant cells. Cancer Res 52: 3157-3163, 1992.
19. 19. Coley HM, Amos WB, Twentyman PR and Workman P, Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines. Br J Cancer 67: 1316-1323, 1993.
20. 20. Keizer HG and Joenje H, Increased cytosolic pH in multidrug-resistant human lung tumor cells: Effect of verapamil. J Natl Cancer Inst 81: 706-709, 1989.
21. 21. Boscoboinik D, Gupta RS and Epand RM, Investigation of the relationship between altered intracellular pH and multidrug resistance in mammalian cells. Br J Cancer 61: 568-572, 1990.
22. 22. Krishnamachary N, Ma L, Zheng L, Safa AR and Center MS, Analysis of MRP gene expression and function in HL60 cells isolated for resistance to Adriamycin. Oncol Res 6: 119-127, 1994.
23. 23. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV and Deeley RG, Overexpression of a transporter gene in a multidrug -resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
24. 24. Jedlitschky G, Leier I, Buchholz U, Center M and Keppler D, ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54: 4833-4836, 1994.
25. 4 and structurally related conjugates. J Biol Chem 269: 27807-27810, 1994.
26. 26. Zaman GJR, Lankelma J, Van Tellingen O, Beijnen J, Dekker H, Paulusma C, Elferink RPJO, Baas F and Borst P, Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92: 7690-7694, 1995.
27. 27. Schneider E, Horton JK, Yang C-H, Nakagawa M and Cowan KH, Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 54: 152-158, 1994.
28. 28. Lorico A, Rappa G, Srimatkandada S, Catapano CV, Fernandes DJ, Germino JF and Sartorelli AC, Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene. Cancer Res 55: 4352-4360, 1995.
29. 29. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J-L, Drumm ML, Iannuzzi MC, Collins FS and Tsui L-C, Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245: 1066-1073, 1989.
30. 30. Sieber SM, Mead JAR and Adamson RH, Pharmacology of antitumor agents from higher plants. Cancer Treat Rep 60: 1127-1139, 1976.
31. 31. Johnson IS, Armstrong JG, Gorman M and Burnett JP Jr, The Vinca alkaloids: A new class of oncolytic agents. Cancer Res 23: 1390-1427, 1963.
32. 32. Gervasoni JE Jr, Fields SZ, Krishna S, Baker MA, Rosado M, Thuraisamy K, Hindenburg AA and Taub RN, Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res 51: 4955-4963, 1991.
33. 33. Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA and Kruh GD, Expression of multidrug resistance-associated protein in NIH-3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 55: 5342-5347, 1995.